nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF2—epilepsy syndrome	0.595	1	CbGaD
Pentosan Polysulfate—FGF1—ganglion—epilepsy syndrome	0.00554	0.12	CbGeAlD
Pentosan Polysulfate—FGF4—head—epilepsy syndrome	0.00503	0.109	CbGeAlD
Pentosan Polysulfate—FGF4—nervous system—epilepsy syndrome	0.00477	0.103	CbGeAlD
Pentosan Polysulfate—FGF1—hindbrain—epilepsy syndrome	0.0042	0.0907	CbGeAlD
Pentosan Polysulfate—FGF1—brainstem—epilepsy syndrome	0.00241	0.052	CbGeAlD
Pentosan Polysulfate—FGF1—forebrain—epilepsy syndrome	0.00232	0.0502	CbGeAlD
Pentosan Polysulfate—FGF2—medulla oblongata—epilepsy syndrome	0.00226	0.0487	CbGeAlD
Pentosan Polysulfate—FGF1—telencephalon—epilepsy syndrome	0.00214	0.0461	CbGeAlD
Pentosan Polysulfate—FGF2—midbrain—epilepsy syndrome	0.00206	0.0445	CbGeAlD
Pentosan Polysulfate—FGF2—spinal cord—epilepsy syndrome	0.00201	0.0435	CbGeAlD
Pentosan Polysulfate—FGF1—medulla oblongata—epilepsy syndrome	0.00168	0.0362	CbGeAlD
Pentosan Polysulfate—FGF2—cerebellum—epilepsy syndrome	0.0016	0.0345	CbGeAlD
Pentosan Polysulfate—FGF1—midbrain—epilepsy syndrome	0.00153	0.0331	CbGeAlD
Pentosan Polysulfate—FGF1—spinal cord—epilepsy syndrome	0.0015	0.0323	CbGeAlD
Pentosan Polysulfate—FGF1—head—epilepsy syndrome	0.00133	0.0287	CbGeAlD
Pentosan Polysulfate—FGF2—brain—epilepsy syndrome	0.0013	0.028	CbGeAlD
Pentosan Polysulfate—FGF1—nervous system—epilepsy syndrome	0.00126	0.0272	CbGeAlD
Pentosan Polysulfate—FGF1—central nervous system—epilepsy syndrome	0.00121	0.0262	CbGeAlD
Pentosan Polysulfate—FGF1—cerebellum—epilepsy syndrome	0.00119	0.0256	CbGeAlD
Pentosan Polysulfate—FGF1—brain—epilepsy syndrome	0.000964	0.0208	CbGeAlD
Pentosan Polysulfate—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000106	0.000499	CcSEcCtD
Pentosan Polysulfate—Constipation—Lamotrigine—epilepsy syndrome	0.000106	0.000499	CcSEcCtD
Pentosan Polysulfate—Nausea—Acetazolamide—epilepsy syndrome	0.000105	0.000498	CcSEcCtD
Pentosan Polysulfate—Dizziness—Levetiracetam—epilepsy syndrome	0.000105	0.000498	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000105	0.000497	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000105	0.000497	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000105	0.000497	CcSEcCtD
Pentosan Polysulfate—Vomiting—Propofol—epilepsy syndrome	0.000105	0.000495	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Topiramate—epilepsy syndrome	0.000105	0.000494	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000104	0.000493	CcSEcCtD
Pentosan Polysulfate—Pruritus—Diazepam—epilepsy syndrome	0.000104	0.000493	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Topiramate—epilepsy syndrome	0.000104	0.000493	CcSEcCtD
Pentosan Polysulfate—Rash—Propofol—epilepsy syndrome	0.000104	0.000491	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Propofol—epilepsy syndrome	0.000104	0.000491	CcSEcCtD
Pentosan Polysulfate—Headache—Propofol—epilepsy syndrome	0.000103	0.000488	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000103	0.000486	CcSEcCtD
Pentosan Polysulfate—Vomiting—Midazolam—epilepsy syndrome	0.000103	0.000484	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000102	0.000484	CcSEcCtD
Pentosan Polysulfate—Myalgia—Valproic Acid—epilepsy syndrome	0.000102	0.000483	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Valproic Acid—epilepsy syndrome	0.000102	0.000483	CcSEcCtD
Pentosan Polysulfate—Haematuria—Topiramate—epilepsy syndrome	0.000102	0.000483	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000102	0.00048	CcSEcCtD
Pentosan Polysulfate—Rash—Midazolam—epilepsy syndrome	0.000102	0.00048	CcSEcCtD
Pentosan Polysulfate—Dizziness—Fosphenytoin—epilepsy syndrome	0.000102	0.00048	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Midazolam—epilepsy syndrome	0.000102	0.00048	CcSEcCtD
Pentosan Polysulfate—Urticaria—Carbamazepine—epilepsy syndrome	0.000101	0.000479	CcSEcCtD
Pentosan Polysulfate—Vomiting—Levetiracetam—epilepsy syndrome	0.000101	0.000478	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Topiramate—epilepsy syndrome	0.000101	0.000478	CcSEcCtD
Pentosan Polysulfate—Alopecia—Gabapentin—epilepsy syndrome	0.000101	0.000478	CcSEcCtD
Pentosan Polysulfate—Discomfort—Valproic Acid—epilepsy syndrome	0.000101	0.000478	CcSEcCtD
Pentosan Polysulfate—Headache—Midazolam—epilepsy syndrome	0.000101	0.000477	CcSEcCtD
Pentosan Polysulfate—Pruritus—Felbamate—epilepsy syndrome	0.000101	0.000477	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000101	0.000477	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Diazepam—epilepsy syndrome	0.000101	0.000477	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000101	0.000477	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000101	0.000476	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Topiramate—epilepsy syndrome	0.000101	0.000475	CcSEcCtD
Pentosan Polysulfate—Rash—Levetiracetam—epilepsy syndrome	0.0001	0.000474	CcSEcCtD
Pentosan Polysulfate—Anaemia—Pregabalin—epilepsy syndrome	0.0001	0.000474	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Levetiracetam—epilepsy syndrome	0.0001	0.000474	CcSEcCtD
Pentosan Polysulfate—Agitation—Pregabalin—epilepsy syndrome	9.98e-05	0.000472	CcSEcCtD
Pentosan Polysulfate—Headache—Levetiracetam—epilepsy syndrome	9.98e-05	0.000471	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Clonazepam—epilepsy syndrome	9.92e-05	0.000469	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vigabatrin—epilepsy syndrome	9.91e-05	0.000468	CcSEcCtD
Pentosan Polysulfate—Pruritus—Zonisamide—epilepsy syndrome	9.89e-05	0.000467	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Phenytoin—epilepsy syndrome	9.85e-05	0.000466	CcSEcCtD
Pentosan Polysulfate—Flatulence—Gabapentin—epilepsy syndrome	9.81e-05	0.000464	CcSEcCtD
Pentosan Polysulfate—Oedema—Valproic Acid—epilepsy syndrome	9.81e-05	0.000463	CcSEcCtD
Pentosan Polysulfate—Urticaria—Lamotrigine—epilepsy syndrome	9.8e-05	0.000463	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.8e-05	0.000463	CcSEcCtD
Pentosan Polysulfate—Malaise—Pregabalin—epilepsy syndrome	9.8e-05	0.000463	CcSEcCtD
Pentosan Polysulfate—Nausea—Propofol—epilepsy syndrome	9.79e-05	0.000463	CcSEcCtD
Pentosan Polysulfate—Vomiting—Fosphenytoin—epilepsy syndrome	9.77e-05	0.000462	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Felbamate—epilepsy syndrome	9.77e-05	0.000462	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Lamotrigine—epilepsy syndrome	9.75e-05	0.000461	CcSEcCtD
Pentosan Polysulfate—Dizziness—Diazepam—epilepsy syndrome	9.75e-05	0.000461	CcSEcCtD
Pentosan Polysulfate—Infection—Valproic Acid—epilepsy syndrome	9.74e-05	0.00046	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Pregabalin—epilepsy syndrome	9.72e-05	0.000459	CcSEcCtD
Pentosan Polysulfate—Rash—Fosphenytoin—epilepsy syndrome	9.69e-05	0.000458	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Fosphenytoin—epilepsy syndrome	9.68e-05	0.000457	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Topiramate—epilepsy syndrome	9.65e-05	0.000456	CcSEcCtD
Pentosan Polysulfate—Headache—Fosphenytoin—epilepsy syndrome	9.63e-05	0.000455	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Valproic Acid—epilepsy syndrome	9.6e-05	0.000454	CcSEcCtD
Pentosan Polysulfate—Nausea—Midazolam—epilepsy syndrome	9.58e-05	0.000453	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Zonisamide—epilepsy syndrome	9.56e-05	0.000452	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Topiramate—epilepsy syndrome	9.55e-05	0.000451	CcSEcCtD
Pentosan Polysulfate—Pruritus—Clonazepam—epilepsy syndrome	9.53e-05	0.00045	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vigabatrin—epilepsy syndrome	9.52e-05	0.00045	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.48e-05	0.000448	CcSEcCtD
Pentosan Polysulfate—Pruritus—Phenytoin—epilepsy syndrome	9.46e-05	0.000447	CcSEcCtD
Pentosan Polysulfate—Nausea—Levetiracetam—epilepsy syndrome	9.46e-05	0.000447	CcSEcCtD
Pentosan Polysulfate—Rash—Vigabatrin—epilepsy syndrome	9.45e-05	0.000446	CcSEcCtD
Pentosan Polysulfate—Dizziness—Felbamate—epilepsy syndrome	9.44e-05	0.000446	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vigabatrin—epilepsy syndrome	9.44e-05	0.000446	CcSEcCtD
Pentosan Polysulfate—Pruritus—Oxcarbazepine—epilepsy syndrome	9.41e-05	0.000445	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.41e-05	0.000445	CcSEcCtD
Pentosan Polysulfate—Headache—Vigabatrin—epilepsy syndrome	9.38e-05	0.000443	CcSEcCtD
Pentosan Polysulfate—Vomiting—Diazepam—epilepsy syndrome	9.38e-05	0.000443	CcSEcCtD
Pentosan Polysulfate—Anorexia—Valproic Acid—epilepsy syndrome	9.35e-05	0.000442	CcSEcCtD
Pentosan Polysulfate—Rash—Diazepam—epilepsy syndrome	9.3e-05	0.000439	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Diazepam—epilepsy syndrome	9.29e-05	0.000439	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Pregabalin—epilepsy syndrome	9.25e-05	0.000437	CcSEcCtD
Pentosan Polysulfate—Myalgia—Pregabalin—epilepsy syndrome	9.25e-05	0.000437	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Gabapentin—epilepsy syndrome	9.24e-05	0.000437	CcSEcCtD
Pentosan Polysulfate—Dizziness—Zonisamide—epilepsy syndrome	9.24e-05	0.000437	CcSEcCtD
Pentosan Polysulfate—Headache—Diazepam—epilepsy syndrome	9.24e-05	0.000437	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Clonazepam—epilepsy syndrome	9.21e-05	0.000435	CcSEcCtD
Pentosan Polysulfate—Anaemia—Gabapentin—epilepsy syndrome	9.21e-05	0.000435	CcSEcCtD
Pentosan Polysulfate—Agitation—Gabapentin—epilepsy syndrome	9.15e-05	0.000433	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Phenytoin—epilepsy syndrome	9.15e-05	0.000432	CcSEcCtD
Pentosan Polysulfate—Discomfort—Pregabalin—epilepsy syndrome	9.14e-05	0.000432	CcSEcCtD
Pentosan Polysulfate—Nausea—Fosphenytoin—epilepsy syndrome	9.13e-05	0.000431	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.1e-05	0.00043	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.09e-05	0.00043	CcSEcCtD
Pentosan Polysulfate—Vomiting—Felbamate—epilepsy syndrome	9.08e-05	0.000429	CcSEcCtD
Pentosan Polysulfate—Pruritus—Carbamazepine—epilepsy syndrome	9.03e-05	0.000427	CcSEcCtD
Pentosan Polysulfate—Rash—Felbamate—epilepsy syndrome	9e-05	0.000425	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Felbamate—epilepsy syndrome	8.99e-05	0.000425	CcSEcCtD
Pentosan Polysulfate—Malaise—Gabapentin—epilepsy syndrome	8.98e-05	0.000424	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Topiramate—epilepsy syndrome	8.97e-05	0.000424	CcSEcCtD
Pentosan Polysulfate—Headache—Felbamate—epilepsy syndrome	8.94e-05	0.000423	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.93e-05	0.000422	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Gabapentin—epilepsy syndrome	8.92e-05	0.000421	CcSEcCtD
Pentosan Polysulfate—Dizziness—Clonazepam—epilepsy syndrome	8.9e-05	0.000421	CcSEcCtD
Pentosan Polysulfate—Nausea—Vigabatrin—epilepsy syndrome	8.9e-05	0.00042	CcSEcCtD
Pentosan Polysulfate—Vomiting—Zonisamide—epilepsy syndrome	8.88e-05	0.00042	CcSEcCtD
Pentosan Polysulfate—Insomnia—Valproic Acid—epilepsy syndrome	8.87e-05	0.000419	CcSEcCtD
Pentosan Polysulfate—Oedema—Pregabalin—epilepsy syndrome	8.86e-05	0.000419	CcSEcCtD
Pentosan Polysulfate—Dizziness—Phenytoin—epilepsy syndrome	8.85e-05	0.000418	CcSEcCtD
Pentosan Polysulfate—Rash—Zonisamide—epilepsy syndrome	8.81e-05	0.000416	CcSEcCtD
Pentosan Polysulfate—Infection—Pregabalin—epilepsy syndrome	8.81e-05	0.000416	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Valproic Acid—epilepsy syndrome	8.8e-05	0.000416	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Zonisamide—epilepsy syndrome	8.8e-05	0.000416	CcSEcCtD
Pentosan Polysulfate—Dizziness—Oxcarbazepine—epilepsy syndrome	8.8e-05	0.000416	CcSEcCtD
Pentosan Polysulfate—Nausea—Diazepam—epilepsy syndrome	8.76e-05	0.000414	CcSEcCtD
Pentosan Polysulfate—Headache—Zonisamide—epilepsy syndrome	8.75e-05	0.000414	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Valproic Acid—epilepsy syndrome	8.74e-05	0.000413	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Carbamazepine—epilepsy syndrome	8.74e-05	0.000413	CcSEcCtD
Pentosan Polysulfate—Pruritus—Lamotrigine—epilepsy syndrome	8.73e-05	0.000413	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Pregabalin—epilepsy syndrome	8.68e-05	0.00041	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Valproic Acid—epilepsy syndrome	8.63e-05	0.000408	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.57e-05	0.000405	CcSEcCtD
Pentosan Polysulfate—Vomiting—Clonazepam—epilepsy syndrome	8.56e-05	0.000405	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Valproic Acid—epilepsy syndrome	8.52e-05	0.000403	CcSEcCtD
Pentosan Polysulfate—Alopecia—Topiramate—epilepsy syndrome	8.51e-05	0.000402	CcSEcCtD
Pentosan Polysulfate—Vomiting—Phenytoin—epilepsy syndrome	8.5e-05	0.000402	CcSEcCtD
Pentosan Polysulfate—Rash—Clonazepam—epilepsy syndrome	8.49e-05	0.000401	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Clonazepam—epilepsy syndrome	8.48e-05	0.000401	CcSEcCtD
Pentosan Polysulfate—Myalgia—Gabapentin—epilepsy syndrome	8.48e-05	0.000401	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Gabapentin—epilepsy syndrome	8.48e-05	0.000401	CcSEcCtD
Pentosan Polysulfate—Nausea—Felbamate—epilepsy syndrome	8.48e-05	0.000401	CcSEcCtD
Pentosan Polysulfate—Vomiting—Oxcarbazepine—epilepsy syndrome	8.46e-05	0.0004	CcSEcCtD
Pentosan Polysulfate—Anorexia—Pregabalin—epilepsy syndrome	8.45e-05	0.000399	CcSEcCtD
Pentosan Polysulfate—Dizziness—Carbamazepine—epilepsy syndrome	8.44e-05	0.000399	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Lamotrigine—epilepsy syndrome	8.44e-05	0.000399	CcSEcCtD
Pentosan Polysulfate—Headache—Clonazepam—epilepsy syndrome	8.44e-05	0.000399	CcSEcCtD
Pentosan Polysulfate—Rash—Phenytoin—epilepsy syndrome	8.43e-05	0.000399	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Phenytoin—epilepsy syndrome	8.43e-05	0.000398	CcSEcCtD
Pentosan Polysulfate—Rash—Oxcarbazepine—epilepsy syndrome	8.39e-05	0.000396	CcSEcCtD
Pentosan Polysulfate—Constipation—Valproic Acid—epilepsy syndrome	8.39e-05	0.000396	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.38e-05	0.000396	CcSEcCtD
Pentosan Polysulfate—Headache—Phenytoin—epilepsy syndrome	8.38e-05	0.000396	CcSEcCtD
Pentosan Polysulfate—Discomfort—Gabapentin—epilepsy syndrome	8.38e-05	0.000396	CcSEcCtD
Pentosan Polysulfate—Headache—Oxcarbazepine—epilepsy syndrome	8.34e-05	0.000394	CcSEcCtD
Pentosan Polysulfate—Nausea—Zonisamide—epilepsy syndrome	8.3e-05	0.000392	CcSEcCtD
Pentosan Polysulfate—Flatulence—Topiramate—epilepsy syndrome	8.26e-05	0.00039	CcSEcCtD
Pentosan Polysulfate—Dizziness—Lamotrigine—epilepsy syndrome	8.16e-05	0.000386	CcSEcCtD
Pentosan Polysulfate—Oedema—Gabapentin—epilepsy syndrome	8.13e-05	0.000384	CcSEcCtD
Pentosan Polysulfate—Vomiting—Carbamazepine—epilepsy syndrome	8.12e-05	0.000384	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.08e-05	0.000382	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.08e-05	0.000382	CcSEcCtD
Pentosan Polysulfate—Infection—Gabapentin—epilepsy syndrome	8.08e-05	0.000382	CcSEcCtD
Pentosan Polysulfate—Rash—Carbamazepine—epilepsy syndrome	8.05e-05	0.00038	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Carbamazepine—epilepsy syndrome	8.04e-05	0.00038	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.02e-05	0.000379	CcSEcCtD
Pentosan Polysulfate—Insomnia—Pregabalin—epilepsy syndrome	8.02e-05	0.000379	CcSEcCtD
Pentosan Polysulfate—Nausea—Clonazepam—epilepsy syndrome	8e-05	0.000378	CcSEcCtD
Pentosan Polysulfate—Headache—Carbamazepine—epilepsy syndrome	8e-05	0.000378	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Pregabalin—epilepsy syndrome	7.96e-05	0.000376	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Gabapentin—epilepsy syndrome	7.96e-05	0.000376	CcSEcCtD
Pentosan Polysulfate—Nausea—Phenytoin—epilepsy syndrome	7.95e-05	0.000375	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Pregabalin—epilepsy syndrome	7.9e-05	0.000373	CcSEcCtD
Pentosan Polysulfate—Nausea—Oxcarbazepine—epilepsy syndrome	7.9e-05	0.000373	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.86e-05	0.000371	CcSEcCtD
Pentosan Polysulfate—Vomiting—Lamotrigine—epilepsy syndrome	7.85e-05	0.000371	CcSEcCtD
Pentosan Polysulfate—Urticaria—Valproic Acid—epilepsy syndrome	7.79e-05	0.000368	CcSEcCtD
Pentosan Polysulfate—Rash—Lamotrigine—epilepsy syndrome	7.78e-05	0.000368	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Topiramate—epilepsy syndrome	7.77e-05	0.000367	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Lamotrigine—epilepsy syndrome	7.77e-05	0.000367	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Valproic Acid—epilepsy syndrome	7.75e-05	0.000366	CcSEcCtD
Pentosan Polysulfate—Anorexia—Gabapentin—epilepsy syndrome	7.75e-05	0.000366	CcSEcCtD
Pentosan Polysulfate—Anaemia—Topiramate—epilepsy syndrome	7.74e-05	0.000366	CcSEcCtD
Pentosan Polysulfate—Headache—Lamotrigine—epilepsy syndrome	7.73e-05	0.000365	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Pregabalin—epilepsy syndrome	7.71e-05	0.000364	CcSEcCtD
Pentosan Polysulfate—Agitation—Topiramate—epilepsy syndrome	7.7e-05	0.000364	CcSEcCtD
Pentosan Polysulfate—Nausea—Carbamazepine—epilepsy syndrome	7.58e-05	0.000358	CcSEcCtD
Pentosan Polysulfate—Constipation—Pregabalin—epilepsy syndrome	7.58e-05	0.000358	CcSEcCtD
Pentosan Polysulfate—Malaise—Topiramate—epilepsy syndrome	7.56e-05	0.000357	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Topiramate—epilepsy syndrome	7.5e-05	0.000354	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.41e-05	0.00035	CcSEcCtD
Pentosan Polysulfate—Insomnia—Gabapentin—epilepsy syndrome	7.35e-05	0.000347	CcSEcCtD
Pentosan Polysulfate—Nausea—Lamotrigine—epilepsy syndrome	7.33e-05	0.000346	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Pregabalin—epilepsy syndrome	7.31e-05	0.000345	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Gabapentin—epilepsy syndrome	7.3e-05	0.000345	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.25e-05	0.000343	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Gabapentin—epilepsy syndrome	7.25e-05	0.000342	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.22e-05	0.000341	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Gabapentin—epilepsy syndrome	7.16e-05	0.000338	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Topiramate—epilepsy syndrome	7.13e-05	0.000337	CcSEcCtD
Pentosan Polysulfate—Myalgia—Topiramate—epilepsy syndrome	7.13e-05	0.000337	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Gabapentin—epilepsy syndrome	7.07e-05	0.000334	CcSEcCtD
Pentosan Polysulfate—Discomfort—Topiramate—epilepsy syndrome	7.05e-05	0.000333	CcSEcCtD
Pentosan Polysulfate—Urticaria—Pregabalin—epilepsy syndrome	7.04e-05	0.000333	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Pregabalin—epilepsy syndrome	7.01e-05	0.000331	CcSEcCtD
Pentosan Polysulfate—Constipation—Gabapentin—epilepsy syndrome	6.95e-05	0.000328	CcSEcCtD
Pentosan Polysulfate—Pruritus—Valproic Acid—epilepsy syndrome	6.94e-05	0.000328	CcSEcCtD
Pentosan Polysulfate—Oedema—Topiramate—epilepsy syndrome	6.84e-05	0.000323	CcSEcCtD
Pentosan Polysulfate—Infection—Topiramate—epilepsy syndrome	6.79e-05	0.000321	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Valproic Acid—epilepsy syndrome	6.71e-05	0.000317	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Gabapentin—epilepsy syndrome	6.7e-05	0.000317	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Topiramate—epilepsy syndrome	6.7e-05	0.000316	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.65e-05	0.000314	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Topiramate—epilepsy syndrome	6.61e-05	0.000312	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Pregabalin—epilepsy syndrome	6.53e-05	0.000309	CcSEcCtD
Pentosan Polysulfate—Anorexia—Topiramate—epilepsy syndrome	6.52e-05	0.000308	CcSEcCtD
Pentosan Polysulfate—Dizziness—Valproic Acid—epilepsy syndrome	6.48e-05	0.000306	CcSEcCtD
Pentosan Polysulfate—Urticaria—Gabapentin—epilepsy syndrome	6.46e-05	0.000305	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Gabapentin—epilepsy syndrome	6.43e-05	0.000304	CcSEcCtD
Pentosan Polysulfate—Pruritus—Pregabalin—epilepsy syndrome	6.27e-05	0.000296	CcSEcCtD
Pentosan Polysulfate—Vomiting—Valproic Acid—epilepsy syndrome	6.23e-05	0.000295	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.23e-05	0.000294	CcSEcCtD
Pentosan Polysulfate—Insomnia—Topiramate—epilepsy syndrome	6.19e-05	0.000292	CcSEcCtD
Pentosan Polysulfate—Rash—Valproic Acid—epilepsy syndrome	6.18e-05	0.000292	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Valproic Acid—epilepsy syndrome	6.18e-05	0.000292	CcSEcCtD
Pentosan Polysulfate—Headache—Valproic Acid—epilepsy syndrome	6.14e-05	0.00029	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Topiramate—epilepsy syndrome	6.14e-05	0.00029	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Topiramate—epilepsy syndrome	6.1e-05	0.000288	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Pregabalin—epilepsy syndrome	6.07e-05	0.000287	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Topiramate—epilepsy syndrome	6.02e-05	0.000284	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Gabapentin—epilepsy syndrome	5.99e-05	0.000283	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Topiramate—epilepsy syndrome	5.94e-05	0.000281	CcSEcCtD
Pentosan Polysulfate—Dizziness—Pregabalin—epilepsy syndrome	5.86e-05	0.000277	CcSEcCtD
Pentosan Polysulfate—Constipation—Topiramate—epilepsy syndrome	5.85e-05	0.000276	CcSEcCtD
Pentosan Polysulfate—Nausea—Valproic Acid—epilepsy syndrome	5.82e-05	0.000275	CcSEcCtD
Pentosan Polysulfate—Pruritus—Gabapentin—epilepsy syndrome	5.75e-05	0.000272	CcSEcCtD
Pentosan Polysulfate—Vomiting—Pregabalin—epilepsy syndrome	5.64e-05	0.000266	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Topiramate—epilepsy syndrome	5.64e-05	0.000266	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.59e-05	0.000264	CcSEcCtD
Pentosan Polysulfate—Rash—Pregabalin—epilepsy syndrome	5.59e-05	0.000264	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Pregabalin—epilepsy syndrome	5.58e-05	0.000264	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Gabapentin—epilepsy syndrome	5.56e-05	0.000263	CcSEcCtD
Pentosan Polysulfate—Headache—Pregabalin—epilepsy syndrome	5.55e-05	0.000262	CcSEcCtD
Pentosan Polysulfate—Urticaria—Topiramate—epilepsy syndrome	5.43e-05	0.000257	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Topiramate—epilepsy syndrome	5.41e-05	0.000255	CcSEcCtD
Pentosan Polysulfate—Dizziness—Gabapentin—epilepsy syndrome	5.38e-05	0.000254	CcSEcCtD
Pentosan Polysulfate—Nausea—Pregabalin—epilepsy syndrome	5.27e-05	0.000249	CcSEcCtD
Pentosan Polysulfate—Vomiting—Gabapentin—epilepsy syndrome	5.17e-05	0.000244	CcSEcCtD
Pentosan Polysulfate—Rash—Gabapentin—epilepsy syndrome	5.13e-05	0.000242	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Gabapentin—epilepsy syndrome	5.12e-05	0.000242	CcSEcCtD
Pentosan Polysulfate—Headache—Gabapentin—epilepsy syndrome	5.09e-05	0.000241	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Topiramate—epilepsy syndrome	5.04e-05	0.000238	CcSEcCtD
Pentosan Polysulfate—Pruritus—Topiramate—epilepsy syndrome	4.84e-05	0.000229	CcSEcCtD
Pentosan Polysulfate—Nausea—Gabapentin—epilepsy syndrome	4.83e-05	0.000228	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Topiramate—epilepsy syndrome	4.68e-05	0.000221	CcSEcCtD
Pentosan Polysulfate—Dizziness—Topiramate—epilepsy syndrome	4.52e-05	0.000214	CcSEcCtD
Pentosan Polysulfate—Vomiting—Topiramate—epilepsy syndrome	4.35e-05	0.000205	CcSEcCtD
Pentosan Polysulfate—Rash—Topiramate—epilepsy syndrome	4.31e-05	0.000204	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Topiramate—epilepsy syndrome	4.31e-05	0.000204	CcSEcCtD
Pentosan Polysulfate—Headache—Topiramate—epilepsy syndrome	4.28e-05	0.000202	CcSEcCtD
Pentosan Polysulfate—Nausea—Topiramate—epilepsy syndrome	4.06e-05	0.000192	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCR3—epilepsy syndrome	1.98e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—AKT1—epilepsy syndrome	1.96e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRH3—epilepsy syndrome	1.94e-05	0.000132	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NPY—epilepsy syndrome	1.93e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.93e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HBEGF—epilepsy syndrome	1.91e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—OPRM1—epilepsy syndrome	1.91e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—FGF2—epilepsy syndrome	1.91e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—RELA—epilepsy syndrome	1.91e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HES1—epilepsy syndrome	1.9e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—BCL2—epilepsy syndrome	1.89e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDC42—epilepsy syndrome	1.88e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—S100B—epilepsy syndrome	1.88e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT3—epilepsy syndrome	1.88e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—epilepsy syndrome	1.87e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SOCS3—epilepsy syndrome	1.86e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL18—epilepsy syndrome	1.86e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—OXT—epilepsy syndrome	1.86e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL2—epilepsy syndrome	1.86e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CRH—epilepsy syndrome	1.86e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HSPB1—epilepsy syndrome	1.86e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL3—epilepsy syndrome	1.86e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDC42—epilepsy syndrome	1.86e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—FYN—epilepsy syndrome	1.85e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—RELA—epilepsy syndrome	1.85e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—H2AFX—epilepsy syndrome	1.84e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MEF2C—epilepsy syndrome	1.84e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ADAM10—epilepsy syndrome	1.83e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—FGF2—epilepsy syndrome	1.82e-05	0.000124	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FYN—epilepsy syndrome	1.81e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MTOR—epilepsy syndrome	1.81e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCR3—epilepsy syndrome	1.8e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MEF2C—epilepsy syndrome	1.8e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—YWHAZ—epilepsy syndrome	1.77e-05	0.000121	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—RELA—epilepsy syndrome	1.77e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NPY—epilepsy syndrome	1.76e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.76e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NGF—epilepsy syndrome	1.75e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—YWHAZ—epilepsy syndrome	1.74e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—MTOR—epilepsy syndrome	1.74e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—BCL2—epilepsy syndrome	1.73e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TSC1—epilepsy syndrome	1.73e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTK2B—epilepsy syndrome	1.73e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—BCL2—epilepsy syndrome	1.72e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HES1—epilepsy syndrome	1.72e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDC42—epilepsy syndrome	1.71e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCR5—epilepsy syndrome	1.71e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL18—epilepsy syndrome	1.7e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL2—epilepsy syndrome	1.7e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL3—epilepsy syndrome	1.7e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HSPB1—epilepsy syndrome	1.7e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—OXT—epilepsy syndrome	1.7e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CRH—epilepsy syndrome	1.7e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—RELA—epilepsy syndrome	1.69e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—FGF2—epilepsy syndrome	1.68e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—RELA—epilepsy syndrome	1.68e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NTRK2—epilepsy syndrome	1.68e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SST—epilepsy syndrome	1.68e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCR2—epilepsy syndrome	1.68e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FYN—epilepsy syndrome	1.67e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HTR2A—epilepsy syndrome	1.67e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—H2AFX—epilepsy syndrome	1.67e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—DUSP6—epilepsy syndrome	1.67e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MTOR—epilepsy syndrome	1.66e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FYN—epilepsy syndrome	1.65e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MTOR—epilepsy syndrome	1.65e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.65e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MEF2C—epilepsy syndrome	1.64e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PLAT—epilepsy syndrome	1.64e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MMP9—epilepsy syndrome	1.62e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—JUN—epilepsy syndrome	1.62e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—RELA—epilepsy syndrome	1.62e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—YWHAZ—epilepsy syndrome	1.61e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—YWHAZ—epilepsy syndrome	1.59e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TSC2—epilepsy syndrome	1.59e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—MTOR—epilepsy syndrome	1.59e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AGT—epilepsy syndrome	1.58e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL12—epilepsy syndrome	1.58e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.58e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—AKT1—epilepsy syndrome	1.58e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TSC1—epilepsy syndrome	1.58e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTK2B—epilepsy syndrome	1.58e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HES1—epilepsy syndrome	1.57e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—TSC2—epilepsy syndrome	1.56e-05	0.000106	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CRP—epilepsy syndrome	1.56e-05	0.000106	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APOE—epilepsy syndrome	1.55e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JUNB—epilepsy syndrome	1.55e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CNR1—epilepsy syndrome	1.55e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CCR5—epilepsy syndrome	1.55e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PLCB1—epilepsy syndrome	1.55e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MTOR—epilepsy syndrome	1.53e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCR2—epilepsy syndrome	1.53e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NTRK2—epilepsy syndrome	1.53e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SST—epilepsy syndrome	1.53e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL1B—epilepsy syndrome	1.53e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—FYN—epilepsy syndrome	1.53e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KDR—epilepsy syndrome	1.52e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—H2AFX—epilepsy syndrome	1.52e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—DUSP6—epilepsy syndrome	1.52e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—epilepsy syndrome	1.52e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HTR7—epilepsy syndrome	1.51e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.5e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—SRC—epilepsy syndrome	1.5e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PLAT—epilepsy syndrome	1.49e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—JUN—epilepsy syndrome	1.48e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—JUN—epilepsy syndrome	1.47e-05	0.0001	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HBEGF—epilepsy syndrome	1.47e-05	9.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—YWHAZ—epilepsy syndrome	1.47e-05	9.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PRKCB—epilepsy syndrome	1.46e-05	9.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—epilepsy syndrome	1.46e-05	9.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6ST—epilepsy syndrome	1.46e-05	9.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—SRC—epilepsy syndrome	1.45e-05	9.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT3—epilepsy syndrome	1.44e-05	9.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL12—epilepsy syndrome	1.44e-05	9.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.44e-05	9.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—AKT1—epilepsy syndrome	1.44e-05	9.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TSC2—epilepsy syndrome	1.44e-05	9.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PRKCB—epilepsy syndrome	1.44e-05	9.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6ST—epilepsy syndrome	1.43e-05	9.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—TSC2—epilepsy syndrome	1.42e-05	9.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CRP—epilepsy syndrome	1.42e-05	9.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—AKT1—epilepsy syndrome	1.42e-05	9.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CNR1—epilepsy syndrome	1.41e-05	9.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUNB—epilepsy syndrome	1.41e-05	9.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CCR5—epilepsy syndrome	1.41e-05	9.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PLCB1—epilepsy syndrome	1.41e-05	9.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ADAM10—epilepsy syndrome	1.41e-05	9.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APOE—epilepsy syndrome	1.41e-05	9.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—SRC—epilepsy syndrome	1.39e-05	9.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HTR7—epilepsy syndrome	1.38e-05	9.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—AKT1—epilepsy syndrome	1.36e-05	9.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HBEGF—epilepsy syndrome	1.34e-05	9.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—POMC—epilepsy syndrome	1.33e-05	9.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—S100B—epilepsy syndrome	1.33e-05	9.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—SRC—epilepsy syndrome	1.33e-05	9.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—SRC—epilepsy syndrome	1.32e-05	8.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6ST—epilepsy syndrome	1.32e-05	8.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SOCS3—epilepsy syndrome	1.32e-05	8.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDC42—epilepsy syndrome	1.32e-05	8.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT3—epilepsy syndrome	1.32e-05	8.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FOS—epilepsy syndrome	1.31e-05	8.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS2—epilepsy syndrome	1.31e-05	8.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TSC2—epilepsy syndrome	1.31e-05	8.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PRKCB—epilepsy syndrome	1.31e-05	8.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6ST—epilepsy syndrome	1.31e-05	8.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL2—epilepsy syndrome	1.31e-05	8.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ADAM10—epilepsy syndrome	1.28e-05	8.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APOE—epilepsy syndrome	1.28e-05	8.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CASP8—epilepsy syndrome	1.28e-05	8.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AVP—epilepsy syndrome	1.27e-05	8.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—SRC—epilepsy syndrome	1.27e-05	8.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—epilepsy syndrome	1.25e-05	8.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—SRC—epilepsy syndrome	1.23e-05	8.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—S100B—epilepsy syndrome	1.21e-05	8.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6ST—epilepsy syndrome	1.21e-05	8.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HES1—epilepsy syndrome	1.2e-05	8.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SOCS3—epilepsy syndrome	1.2e-05	8.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDC42—epilepsy syndrome	1.2e-05	8.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FOS—epilepsy syndrome	1.2e-05	8.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS2—epilepsy syndrome	1.2e-05	8.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—FGF2—epilepsy syndrome	1.18e-05	8.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FYN—epilepsy syndrome	1.17e-05	7.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CASP8—epilepsy syndrome	1.17e-05	7.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—H2AFX—epilepsy syndrome	1.17e-05	7.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MEF2C—epilepsy syndrome	1.17e-05	7.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AVP—epilepsy syndrome	1.16e-05	7.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FGF2—epilepsy syndrome	1.16e-05	7.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.13e-05	7.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NGF—epilepsy syndrome	1.11e-05	7.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BCL2—epilepsy syndrome	1.1e-05	7.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HES1—epilepsy syndrome	1.1e-05	7.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RELA—epilepsy syndrome	1.1e-05	7.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCR5—epilepsy syndrome	1.08e-05	7.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—RELA—epilepsy syndrome	1.08e-05	7.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MTOR—epilepsy syndrome	1.07e-05	7.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FGF2—epilepsy syndrome	1.07e-05	7.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FYN—epilepsy syndrome	1.07e-05	7.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—H2AFX—epilepsy syndrome	1.06e-05	7.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MEF2C—epilepsy syndrome	1.06e-05	7.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HTR2A—epilepsy syndrome	1.06e-05	7.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MTOR—epilepsy syndrome	1.05e-05	7.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.03e-05	6.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NGF—epilepsy syndrome	1.02e-05	6.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TSC2—epilepsy syndrome	1.01e-05	6.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AGT—epilepsy syndrome	1.01e-05	6.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2—epilepsy syndrome	1e-05	6.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCR5—epilepsy syndrome	9.88e-06	6.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—epilepsy syndrome	9.88e-06	6.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOE—epilepsy syndrome	9.86e-06	6.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—RELA—epilepsy syndrome	9.8e-06	6.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTOR—epilepsy syndrome	9.73e-06	6.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL1B—epilepsy syndrome	9.72e-06	6.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HTR2A—epilepsy syndrome	9.67e-06	6.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KDR—epilepsy syndrome	9.66e-06	6.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—epilepsy syndrome	9.64e-06	6.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MTOR—epilepsy syndrome	9.61e-06	6.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—JUN—epilepsy syndrome	9.59e-06	6.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—JUN—epilepsy syndrome	9.42e-06	6.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—epilepsy syndrome	9.33e-06	6.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—epilepsy syndrome	9.31e-06	6.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PRKCB—epilepsy syndrome	9.3e-06	6.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6ST—epilepsy syndrome	9.26e-06	6.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TSC2—epilepsy syndrome	9.18e-06	6.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AGT—epilepsy syndrome	9.17e-06	6.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—epilepsy syndrome	9.01e-06	6.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOE—epilepsy syndrome	8.99e-06	6.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTOR—epilepsy syndrome	8.88e-06	6.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL1B—epilepsy syndrome	8.86e-06	6.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KDR—epilepsy syndrome	8.81e-06	5.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—epilepsy syndrome	8.8e-06	5.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—epilepsy syndrome	8.66e-06	5.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SRC—epilepsy syndrome	8.61e-06	5.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JUN—epilepsy syndrome	8.59e-06	5.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PRKCB—epilepsy syndrome	8.48e-06	5.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—POMC—epilepsy syndrome	8.47e-06	5.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SRC—epilepsy syndrome	8.45e-06	5.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6ST—epilepsy syndrome	8.44e-06	5.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—epilepsy syndrome	8.38e-06	5.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL2—epilepsy syndrome	8.28e-06	5.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—epilepsy syndrome	8.27e-06	5.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—epilepsy syndrome	8.22e-06	5.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—epilepsy syndrome	7.89e-06	5.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SRC—epilepsy syndrome	7.8e-06	5.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—POMC—epilepsy syndrome	7.72e-06	5.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SRC—epilepsy syndrome	7.7e-06	5.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—epilepsy syndrome	7.64e-06	5.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL2—epilepsy syndrome	7.56e-06	5.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGF2—epilepsy syndrome	7.49e-06	5.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SRC—epilepsy syndrome	7.11e-06	4.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RELA—epilepsy syndrome	6.95e-06	4.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MTOR—epilepsy syndrome	6.82e-06	4.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RELA—epilepsy syndrome	6.34e-06	4.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—epilepsy syndrome	6.27e-06	4.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MTOR—epilepsy syndrome	6.22e-06	4.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JUN—epilepsy syndrome	6.09e-06	4.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—epilepsy syndrome	5.92e-06	4.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—epilepsy syndrome	5.72e-06	3.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUN—epilepsy syndrome	5.55e-06	3.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SRC—epilepsy syndrome	5.46e-06	3.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—epilepsy syndrome	5.4e-06	3.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—epilepsy syndrome	5.35e-06	3.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—epilepsy syndrome	5.32e-06	3.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—epilepsy syndrome	5.25e-06	3.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SRC—epilepsy syndrome	4.98e-06	3.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—epilepsy syndrome	4.85e-06	3.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—epilepsy syndrome	4.85e-06	3.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—epilepsy syndrome	4.79e-06	3.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—epilepsy syndrome	4.42e-06	3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—epilepsy syndrome	3.39e-06	2.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—epilepsy syndrome	3.1e-06	2.1e-05	CbGpPWpGaD
